Supplemental Figure 2 from BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer

Authors :: Arul M. Chinnaiyan
Felix Y. Feng
Shaomeng Wang
Nora M. Navone
Stephen R. Plymate
June Escara-Wilke
Ingrid J. Apel
Pranathi M. Krishnamurthy
Vijaya L. Dommeti
Kari Wilder-Romans
Irfan A. Asangani
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Direct comparison of various BET inhibitors in prostate cancer cells.

Full Text Access

Tools